Benzinga’s Top Pre- Market Gainers (TRBN, LGND, DYAX, VRGY, HIBB, NLST)

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN) jumped 16.34% to $4.70 in the pre-market session. The 52 week trading range for TRBN is $1.00 - $6.75. So far in 2009, TRBN gained over 218%.

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) moved up 14.29% to $2.40 after Ligand Pharmaceuticals announced new preclinical data on SARM molecule LGD-4033. In the last six months, LGND declined by over 24%. Yesterday, LGND closed at $2.10.

Dyax Corp. (NASDAQ: DYAX) surged 4.25% or $0.15 to $3.80 in the pre-market session. Yesterday, DYAX closed at $3.65. In the last six months, Dyax gained over 60%.

Verigy Ltd. (NASDAQ: VRGY) climbed 11% to $10. Yesterday, VRGY announced that it expects 1Q2010 revenue to be in between $105 to $115 million and loss per share to be in between $0.13 to $0.06. Analysts on an average are expecting VRGY to report loss per share of $0.14 on revenue of $106 million for the first quarter of 2010. VRGY declined by around 6% so far in 2009.

Hibbett Sports, Inc. (NASDAQ: HIBB) increased 5.48% to $20.01 after HIBB raised its earning guidance for the financial year 2010. Yesterday, HIBB closed at $18.97.

Netlist, Inc. (NASDAQ: NLST) moved up 10.93% to $6.29 in the pre-market session. The 52 week trading range for NLST is $0.11 and $6.87. Yesterday, NLST closed at $5.67.